ARCHIVES

FDA Approved More Than 50 New Indications For Cancer In 32 Months, Analysis Finds

This article is from The Cancer Letter archive.

Vol. 36 No. 06 | February 19, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Breast Cancer Projects To Pay For Concurrent Pathology Review; Laetrile Study Entry Closed

May 19, 1978

ODAC Calls For Tougher Standards For Accelerated Approval In Oncology

February 11, 2011

ASCO Draft Recommendations Define Meaningful Trial Outcomes

April 26, 2013

Angiogenesis Inhibitor In Phase III Trials For Metastatic Colorectal Cancer

September 26, 2003

SWOG Wins Funding For H. Pylori Trial.

November 21, 2008

In Brief: Bogardus Heads ASTRO, Million President Elect; Woods Named Chief of NIC Contracts Review

October 27, 1989